Letter to the editor regarding: 'The impact of body mass index on the efficacy of CDK4/6 inhibitors in patients with metastatic breast cancer'.

Ann Med · 2026 · PMC12777992 · PMID 41457854

Europe PMC DOI

hedged sentence

0.4880

closest p · 9.8× alpha

0.4880

boldest claim

The sentences

did not reach statistical significancep = 0.488not close (p > 0.1)

While OS differed in the first-line setting, progression-free survival – a more direct measure of drug activity – did not reach statistical significance ( p = 0.488).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.